CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 1,123 shares at $11.54 ($12,956)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 1,527 shares at $11.54 ($17,617)
- 4 Grant or award CEO acquired 86,655 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 297 shares at $13.11 ($3,895)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 1,545 shares at an average $26.61 ($41,115)
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 403 shares at $17.33 ($6,983)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 767 shares at $17.33 ($13,290)
- 4 Grant or award EVP, CHIEF BUSINESS OFFICER acquired 37,593 shares (grant or award)
- 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 31,709 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 53,499 shares (grant or award)
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 302 shares at $17.63 ($5,323)
- 4 Open-market sale Chief Financial Officer sold 1,744 shares at $25.70 ($44,821)
- 4 Open-market sale CEO sold 18,252 shares at $26.95 ($491,979)
- 4 Grant or award EVP, Chief Business Officer acquired 3,472 shares (grant or award)
- 4 Grant or award EVP/Chief Medical Officer acquired 4,243 shares (grant or award)
Page 7 of 18 · 351 filings